Emetine and the Alternative Splicing of Bcl-X: Where to next?

0Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Interference with the alternative splicing of apoptotic factors offers an innovative and specific mechanism to target malignant cells. In this issue of Chemistry & Biology, Zhou et al. [1] report on the regulation of the alternative splicing of Bcl-x pre-mRNA in response to emetine, a potent protein synthesis inhibitor, as well as define a major player in the signaling mechanism. © 2007 Elsevier Ltd. All rights reserved.

Cite

CITATION STYLE

APA

Shultz, J. C., & Chalfant, C. E. (2007, December 26). Emetine and the Alternative Splicing of Bcl-X: Where to next? Chemistry and Biology. https://doi.org/10.1016/j.chembiol.2007.12.002

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free